932041-14-0

Basic information

• Product Name: 1H-Indazole-3-carboxylicacid,4-chloro-,Methylester
• Synonyms: 1H-Indazole-3-carboxylicacid,4-chloro-,Methylester;4-Chloro-1H-indazole-3-carboxylic acid methyl ester
• CAS NO: 932041-14-0
• Molecular Formula: C9H7ClN2O2
• Molecular Weight: 210.61708
• Mol File: 932041-14-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Indazole-3-carboxylicacid,4-chloro-,Methylester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indazole-3-carboxylicacid,4-chloro-,Methylester(932041-14-0)
• EPA Substance Registry System: 1H-Indazole-3-carboxylicacid,4-chloro-,Methylester(932041-14-0)

Safety Data

• Hazardous Substances Data: 932041-14-0(Hazardous Substances Data)

Usage

Molecular Weight

211.64

Structure

A heterocyclic compound consisting of an indazole ring with a carboxylic acid group at the 3-position and a methyl ester group at the 4-position, with a chlorine substituent attached to the indazole ring.

+ Appearance

Pale yellow solid

+ Melting Point

Not provided

+ Solubility

Not provided

+ Reactivity

Can undergo reactions typical of indazole derivatives, such as electrophilic substitution and nucleophilic substitution.

+ Stability

Stable under normal conditions, but may decompose upon exposure to heat or light.

Biological Activity

Exhibits potential biological activity, particularly as a potential drug candidate for the treatment of various diseases.

Medicinal Chemistry Applications

Has potential applications in the field of medicinal chemistry due to its biological activity and structure.

Research and Development

Is a promising candidate for further study and development in pharmaceutical research.

Upstream product

• 13096-96-3 4-chloro-1H-indazole 
• 387-45-1 2-chloro-6-fluorobenzaldehyde 
• 67-56-1 methanol 
• 201230-82-2 carbon monoxide 
• 518990-33-5 4-chloro-3-iodo-1H-indazole 

Relevant articles and documents

ALKYNYL ALCOHOLS AND METHODS OF USE

The invention relates to compounds of Formula (0): wherein Q, A1-A8, R4 and R5 and each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over- activation of NF-kB signaling is observed.

CONDENSED PYRAZOLE DERIVATIVES AS PPAR AGONISTS II

The invention discloses compounds of formula (I) wherein: R is a carboxylic acid or a derivative thereof; R1 and R2 are independently H or alkyl, or together R1 and R2 form an alkylene group; L1 is a